IGF1 and Insulin resistance: A recent population-based cohort study demonstrated that PPI use was associated with increased insulin resistance as measured by HOMA-IR levels; possible mechanisms include PPI-induced hypomagnesemia and suppression of insulin-like growth factor-1(IGF-1) due to PPIs [6–9].